蚌埠医学院学报
蚌埠醫學院學報
방부의학원학보
ACTA ACADEMIAE MEDICINAE BENGBU
2015年
4期
453-455
,共3页
庾建英%刘继新%李春丽%王志丹%李文娟
庾建英%劉繼新%李春麗%王誌丹%李文娟
유건영%류계신%리춘려%왕지단%리문연
脑血管意外%超敏C反应蛋白%预后
腦血管意外%超敏C反應蛋白%預後
뇌혈관의외%초민C반응단백%예후
cerebral vascular accident%high sensitivity C-reactive protein%prognosis
目的::探讨急性脑卒中患者超敏C反应蛋白( hs-CRP)的动态演变与预后关系。方法:将急性脑卒中患者184例分为缺血性脑卒中102例(缺血组)和出血性脑卒中82例(出血组)。分别于治疗前、治疗后1、2、3、4、6、8周测血hs-CRP水平。并随访1年,观察再发脑卒中情况。结果:2例在发病后2周病死予以剔除。2组患者治疗后1~8周hs-CRP均较治疗前显著降低(P<0.01),治疗后2~8周hs-CRP亦均明显低于治疗后1周(P<0.01)。缺血组患者治疗前后1~8周hs-CRP水平均低于出血组(P<0.05~P<0.01)。2组随访观察1年,hs-CRP持续未恢复正常者再发脑血管病率为44.23%,高于hs-CRP恢复正常者的发生率为11.72%(P<0.01)。结论:急性缺血性脑卒中及急性出血性脑卒中发生后,hs-CRP均明显增高,但急性缺血性脑卒中hs-CRP恢复较急性出血性脑卒中快,hs-CRP持续未恢复者再发脑血管病的概率增高。
目的::探討急性腦卒中患者超敏C反應蛋白( hs-CRP)的動態縯變與預後關繫。方法:將急性腦卒中患者184例分為缺血性腦卒中102例(缺血組)和齣血性腦卒中82例(齣血組)。分彆于治療前、治療後1、2、3、4、6、8週測血hs-CRP水平。併隨訪1年,觀察再髮腦卒中情況。結果:2例在髮病後2週病死予以剔除。2組患者治療後1~8週hs-CRP均較治療前顯著降低(P<0.01),治療後2~8週hs-CRP亦均明顯低于治療後1週(P<0.01)。缺血組患者治療前後1~8週hs-CRP水平均低于齣血組(P<0.05~P<0.01)。2組隨訪觀察1年,hs-CRP持續未恢複正常者再髮腦血管病率為44.23%,高于hs-CRP恢複正常者的髮生率為11.72%(P<0.01)。結論:急性缺血性腦卒中及急性齣血性腦卒中髮生後,hs-CRP均明顯增高,但急性缺血性腦卒中hs-CRP恢複較急性齣血性腦卒中快,hs-CRP持續未恢複者再髮腦血管病的概率增高。
목적::탐토급성뇌졸중환자초민C반응단백( hs-CRP)적동태연변여예후관계。방법:장급성뇌졸중환자184례분위결혈성뇌졸중102례(결혈조)화출혈성뇌졸중82례(출혈조)。분별우치료전、치료후1、2、3、4、6、8주측혈hs-CRP수평。병수방1년,관찰재발뇌졸중정황。결과:2례재발병후2주병사여이척제。2조환자치료후1~8주hs-CRP균교치료전현저강저(P<0.01),치료후2~8주hs-CRP역균명현저우치료후1주(P<0.01)。결혈조환자치료전후1~8주hs-CRP수평균저우출혈조(P<0.05~P<0.01)。2조수방관찰1년,hs-CRP지속미회복정상자재발뇌혈관병솔위44.23%,고우hs-CRP회복정상자적발생솔위11.72%(P<0.01)。결론:급성결혈성뇌졸중급급성출혈성뇌졸중발생후,hs-CRP균명현증고,단급성결혈성뇌졸중hs-CRP회복교급성출혈성뇌졸중쾌,hs-CRP지속미회복자재발뇌혈관병적개솔증고。
Objective:To investigate the relationship between the dynamic change of high sensitivity C-reactive protein( hs-CRP) and prognosis in patients with acute stroke. Methods:One hundred and eighty-four patients with acute stroke were divided into the ischemic stroke group(n=102) and hemorrhagic stroke group(n=82). The levels of hs-CRP in all patients were measured before treatment and after 1,2,3,4,6 and 8 weeks of treatment. The recurrence of stroke was observed during the 1-year of following up. Results:2 patients died after onset two weeks and were removaled. The levels of hs-CRP in two groups after treatment 1 to 8 weeks compared with prior treatment all decreased significantly(P<0. 01). The levels of hs-CRP after treatment 2 to 8 weeks compared with post-treatment 1 week decreased significantly too(P<0. 01). The level of hs-CRP in ischemic stroke group on prior treatment and post-treatment 1 to 8 weeks compared with hemorrhagic stroke group all decreased significantly(P<0. 05~P<0. 01). All patients were followed up for 1 year,the recurrence rate of stroke in the patients with abnormal hs-CRP level(44. 23%) was higher than that in the patients with normal hs-CRP level(11. 72%)(P<0. 01). Conclusions:The levels of hs-CRP in ischemic stroke group and hemorrhagic stroke group increase significantly,but the recovery of the level of hs-CRP in ischemic stroke group is more quick than that in hemorrhagic stroke group,and the recurrence rate of stroke in the patients with abnormal hs-CRP level increases.